• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦南部地区疟原虫现场分离株中与耐药性相关的多态性的流行情况。

Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.

机构信息

Malaria Research Lab, Infectious Diseases Unit, Department of Medicine, Karolinska University Hospital/Karolinska Institutet, Retziusväg 10, Stockholm, Sweden.

出版信息

Malar J. 2011 Jan 28;10:18. doi: 10.1186/1475-2875-10-18.

DOI:10.1186/1475-2875-10-18
PMID:21272384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3037930/
Abstract

BACKGROUND

Scarce data are available on Plasmodium falciparum anti-malarial drug resistance in Pakistan. The aim of this study was, therefore, to determine the prevalence of P. falciparum resistance associated polymorphisms in field isolates from southern Pakistan.

METHODS

Blood samples from 244 patients with blood-slide confirmed P. falciparum mono-infections were collected between 2005-2007. Single nucleotide polymorphisms in the P. falciparum chloroquine resistance transporter (pfcrt K76T), multi drug resistance (pfmdr1 N86Y), dihydrofolate reductase (pfdhfr A16V, N51I, C59R, S108N, I164L) and dihydropteroate synthetase (pfdhps A436S, G437A and E540K) genes and pfmdr1 gene copy numbers were determined using PCR based methods.

RESULTS

The prevalence of pfcrt 76T and pfmdr1 86Y was 93% and 57%, respectively. The prevalence of pfdhfr double mutations 59R + 108N/51R + 108N was 92%. The pfdhfr triple mutation (51I, 59R, 108N) occurred in 3% of samples. The pfdhfr (51I, 59R, 108N) and pfdhps (437G, 540E) quintuple mutation was found in one isolate. Pfdhps 437G was observed in 51% and 540E in 1% of the isolates. One isolate had two pfmdr1 copies and carried the pfmdr1 86Y and pfcrt 76T alleles.

CONCLUSIONS

The results indicate high prevalence of in vivo resistance to chloroquine, whereas high grade resistance to sulphadoxine-pyrimethamine does not appear to be widespread among P. falciparum in southern Pakistan.

摘要

背景

关于巴基斯坦恶性疟原虫抗疟药物耐药性的数据十分有限。因此,本研究旨在确定来自巴基斯坦南部地区现场分离株中恶性疟原虫耐药相关突变的流行率。

方法

2005-2007 年间,采集了 244 例经血片证实的恶性疟原虫单一感染患者的血样。采用 PCR 方法检测恶性疟原虫氯喹耐药转运蛋白(pfcrt K76T)、多药耐药基因(pfmdr1 N86Y)、二氢叶酸还原酶(pfdhfr A16V、N51I、C59R、S108N、I164L)和二氢蝶酸合成酶(pfdhps A436S、G437A 和 E540K)基因中的单核苷酸多态性和 pfmdr1 基因拷贝数。

结果

pfcrt 76T 和 pfmdr1 86Y 的流行率分别为 93%和 57%。pfdhfr 双突变 59R + 108N/51R + 108N 的流行率为 92%。pfdhfr 三突变(51I、59R、108N)发生在 3%的样本中。pfdhfr(51I、59R、108N)和 pfdhps(437G、540E)五突变在 1 个分离株中发现。pfdhps 437G 在 51%的分离株中观察到,540E 在 1%的分离株中观察到。1 个分离株有两个 pfmdr1 拷贝,携带 pfmdr1 86Y 和 pfcrt 76T 等位基因。

结论

结果表明,体内对氯喹的耐药性流行率很高,而对磺胺多辛-乙胺嘧啶的高级耐药性在巴基斯坦南部的恶性疟原虫中似乎并不普遍。

相似文献

1
Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.巴基斯坦南部地区疟原虫现场分离株中与耐药性相关的多态性的流行情况。
Malar J. 2011 Jan 28;10:18. doi: 10.1186/1475-2875-10-18.
2
Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.塞内加尔达喀尔地区恶性疟原虫耐药相关分子标志物的流行情况。
Malar J. 2012 Jun 13;11:197. doi: 10.1186/1475-2875-11-197.
3
Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).赤道几内亚巴塔地区恶性疟原虫pfdhfr、pfdhps、pfmdr1和pfcrt基因的分子突变概况与对不同抗疟药物的耐药性相关
Malar J. 2017 Jan 13;16(1):28. doi: 10.1186/s12936-016-1672-0.
4
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.在伊朗将磺胺多辛-乙胺嘧啶作为一线治疗药物引入之前,恶性疟原虫分离株中与抗疟药物相关的突变流行情况。
Malar J. 2007 Nov 13;6:148. doi: 10.1186/1475-2875-6-148.
5
A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.巴基斯坦恶性疟原虫抗疟耐药性相关多态性的全面调查。
Malar J. 2013 Aug 29;12:300. doi: 10.1186/1475-2875-12-300.
6
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.恶性疟原虫耐药性标志物的分子监测显示,在卢旺达疟疾传播强度不同的两个地点,氯喹敏感性部分恢复,但磺胺多辛-乙胺嘧啶耐药性持续存在。
Acta Trop. 2016 Dec;164:329-336. doi: 10.1016/j.actatropica.2016.09.008. Epub 2016 Sep 17.
7
Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.巴基斯坦恶性疟原虫中磺胺多辛-乙胺嘧啶和青蒿素耐药相关分子标志物的流行情况。
Malar J. 2018 Dec 17;17(1):471. doi: 10.1186/s12936-018-2620-y.
8
Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: Prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes.喀麦隆中部和阿达马瓦地区的抗疟药耐药性:疟原虫 CRT、Pfmdr1、Pfdhfr 和 Pfdhps 基因的突变流行率。
PLoS One. 2021 Aug 19;16(8):e0256343. doi: 10.1371/journal.pone.0256343. eCollection 2021.
9
Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.印度奥里萨邦恶性疟原虫分离株中抗疟药耐药基因的分子监测。
Malar J. 2022 Dec 24;21(1):394. doi: 10.1186/s12936-022-04403-3.
10
Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.在沙特阿拉伯西南部的吉赞地区,与磺胺多辛-乙胺嘧啶耐药相关的 pfdhfr 和 pfdhps 突变在恶性疟原虫分离株中的流行率增加:对疟疾治疗政策的重要影响。
Malar J. 2020 Dec 2;19(1):446. doi: 10.1186/s12936-020-03524-x.

引用本文的文献

1
Evaluation of Drug Resistant Genotypes to Fansidar and Chloroquine by Studying Mutation in and Genes in Isolates from Laghman Province, Afghanistan.通过研究阿富汗拉格曼省分离株中 和 基因的突变来评估对 Fansidar 和氯喹的耐药基因型
Iran J Parasitol. 2022 Jan-Mar;17(1):18-27. doi: 10.18502/ijpa.v17i1.9012.
2
Molecular surveillance of drug resistance: Plasmodium falciparum artemisinin resistance single nucleotide polymorphisms in Kelch protein propeller (K13) domain from Southern Pakistan.分子耐药监测:来自巴基斯坦南部的疟原虫青蒿素耐药单核苷酸多态性在 Kelch 蛋白螺旋桨(K13)结构域。
Malar J. 2021 Apr 7;20(1):176. doi: 10.1186/s12936-021-03715-0.
3
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.2018-2019 年在巴基斯坦对与青蒿素类复方疗法耐药相关的疟原虫遗传标记进行监测。
Malar J. 2020 Jun 8;19(1):206. doi: 10.1186/s12936-020-03276-8.
4
Epidemiology of malaria and chloroquine resistance in Mizoram, northeastern India, a malaria-endemic region bordering Myanmar.印度东北部米佐拉姆邦的疟疾和氯喹耐药性的流行病学研究,该邦是一个疟疾流行地区,与缅甸接壤。
Malar J. 2020 Feb 27;19(1):95. doi: 10.1186/s12936-020-03170-3.
5
Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.巴基斯坦恶性疟原虫中磺胺多辛-乙胺嘧啶和青蒿素耐药相关分子标志物的流行情况。
Malar J. 2018 Dec 17;17(1):471. doi: 10.1186/s12936-018-2620-y.
6
Imported and autochthonous malaria in West Saudi Arabia: results from a reference hospital.沙特阿拉伯西部的输入性和本地疟疾:一家参考医院的结果。
Malar J. 2018 Aug 7;17(1):286. doi: 10.1186/s12936-018-2438-7.
7
Commentary: Malaria elimination in India and regional implications.评论:印度的疟疾消除及其区域影响。
Front Microbiol. 2018 May 15;9:992. doi: 10.3389/fmicb.2018.00992. eCollection 2018.
8
Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.印度奥里萨邦两种不同生态类型中恶性疟原虫耐药基因的突变流行情况比较评估。
Infect Genet Evol. 2016 Jul;41:47-55. doi: 10.1016/j.meegid.2016.03.014. Epub 2016 Mar 15.
9
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.青蒿琥酯加磺胺多辛-乙胺嘧啶治疗阿富汗恶性疟原虫疟疾的临床试验:引入十年后疗效仍得以维持。
Malar J. 2016 Feb 25;15:121. doi: 10.1186/s12936-016-1167-z.
10
Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.阿萨姆邦疟疾流行地区恶性疟原虫野外分离株中与磺胺多辛-乙胺嘧啶耐药性相关的基因多态性
J Postgrad Med. 2015 Jan-Mar;61(1):9-14. doi: 10.4103/0022-3859.147019.

本文引用的文献

1
Declaration of Helsinki. Ethical principles for medical research involving human subjects.《赫尔辛基宣言》。涉及人类受试者的医学研究伦理原则。
J Indian Med Assoc. 2009 Jun;107(6):403-5.
2
Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.印度地区疟原虫分离株中与乙胺嘧啶抗性相关的二氢叶酸还原酶基因周围遗传漂变的特征。
Antimicrob Agents Chemother. 2009 Dec;53(12):5173-80. doi: 10.1128/AAC.00045-09. Epub 2009 Sep 28.
3
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.在肯尼亚恶性疟原虫分离株中哌喹、青蒿琥酯和二氢青蒿素的体外活性以及 pfcrt 和 pfmdr1 的多态性。
Antimicrob Agents Chemother. 2009 Dec;53(12):5069-73. doi: 10.1128/AAC.00638-09. Epub 2009 Sep 21.
4
Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan.来自巴基斯坦疟疾流行地区的间日疟原虫和恶性疟原虫中抗疟药物耐药性突变的流行情况。
Am J Trop Med Hyg. 2009 Sep;81(3):525-8.
5
Origins and spread of pfdhfr mutant alleles in Plasmodium falciparum.恶性疟原虫 pfdhfr 突变等位基因的起源和传播。
Acta Trop. 2010 Jun;114(3):166-70. doi: 10.1016/j.actatropica.2009.07.008. Epub 2009 Jul 14.
6
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.对恶性疟原虫抗寄生虫分子标志物与治疗结果之间相关性证据的系统评价和荟萃分析。
Malar J. 2009 May 4;8:89. doi: 10.1186/1475-2875-8-89.
7
Prevalence of human malaria infection in bordering areas of East Balochistan, adjoining with Punjab: Loralai and Musakhel.俾路支省东部与旁遮普省接壤地区(洛拉莱和穆萨凯尔)的人类疟疾感染率
J Pak Med Assoc. 2009 Mar;59(3):132-5.
8
In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.在非洲用蒿甲醚-本芴醇治疗后,体内选择携带对氯喹敏感的恶性疟原虫pfcrt K76等位基因的疟原虫。
J Infect Dis. 2009 Mar 1;199(5):750-7. doi: 10.1086/596738.
9
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.在伊朗将磺胺多辛-乙胺嘧啶作为一线治疗药物引入之前,恶性疟原虫分离株中与抗疟药物相关的突变流行情况。
Malar J. 2007 Nov 13;6:148. doi: 10.1186/1475-2875-6-148.
10
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.pfmdr1在非洲恶性疟原虫对蒿甲醚-本芴醇耐受性中的作用。
Trop Med Int Health. 2007 Jun;12(6):736-42. doi: 10.1111/j.1365-3156.2007.01843.x.